Skip to main content
SpringerLink
Log in

Therapeutic Ratio of Reirradiation with Cytotoxic Drugs and Other Response-Modifying Agents

  • Chapter
  • First Online:
Re-Irradiation: New Frontiers

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1281 Accesses

Abstract

The introduction of combined modality approaches was a highly significant step in the evolution of curative radiation treatment. Achieving a favorable balance between tumor cell kill and normal tissue toxicity is important, especially in the context of reirradiation. As a result of previous treatments, which often include surgery and chemotherapy, function and reserve capacity of tissues and organs are impaired. Therefore, strategies that could increase the tumor cell kill of reirradiation without increasing serious toxicities would improve the therapeutic index. Two major examples where reirradiation often is combined with concomitant chemotherapy are head and neck tumors and rectal cancer. Compared with the systematic experimental models used for development of first-line combinations and their evaluation through a classic series of clinical trials including randomized phase III studies, development of sound combination regimens for reirradiation is still in its infancy. The clinical situation is complicated by more heterogeneous tumors with changes in physiological and microenvironmental parameters over time and quite variable pretreatment approaches, time intervals, irradiated volumes, etc. This chapter summarizes the principles of combined modality treatment and studies performed in the reirradiation setting.

The original version of this chapter was revised. An erratum to this chapter can be found at 10.1007/978-3-319-41825-4_78.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Albertella MR, Green CM, Lehmann AR et al (2005) A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res 65:9799–9806

    Article  CAS  PubMed  Google Scholar 

  • Altaha R, Liang X, Yu JJ et al (2004) Excision repair cross complementing-group 1: gene expression and platinum resistance. Int J Mol Med 14:959–970

    CAS  PubMed  Google Scholar 

  • Amorino GP, Freeman ML, Carbone DP et al (1999) Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition. Int J Radiat Oncol Biol Phys 44:399–405

    Article  CAS  PubMed  Google Scholar 

  • Aratani Y, Yoshiga K, Mizuuchi H et al (1997) Antitumor effect of carboplatin combined with radiation on tumors in mice. Anticancer Res 17:2535–2538

    CAS  PubMed  Google Scholar 

  • Arcicasa M, Roncadin M, Bidoli E et al (1999) Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 43:789–793

    Article  CAS  PubMed  Google Scholar 

  • Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049

    Article  CAS  PubMed  Google Scholar 

  • Baumann M, Liertz C, Baisch H et al (1994) Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice. Radiother Oncol 32:137–143

    Article  CAS  PubMed  Google Scholar 

  • Begg AC (1990) Cisplatin and radiation: interaction probabilities and therapeutic possibilities. Int J Radiat Oncol Biol Phys 19:1183–1189

    Article  CAS  PubMed  Google Scholar 

  • Belka C (2006) The fate of irradiated tumor cells. Oncogene 25:969–971

    Article  CAS  PubMed  Google Scholar 

  • Berrios M, Osheroff N, Fisher PA (1985) In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. Proc Natl Acad Sci U S A 82:4142–4146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Biagioli MC, Narvey M, Roman E et al (2007) Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 69:1067–1073

    Article  PubMed  Google Scholar 

  • Blanchard P, Baujat B, Holostenco V et al (2011) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 100:33–40

    Article  PubMed  Google Scholar 

  • Blommaert FA, van Dijk-Knijnenburg HCM, Dijt FJ et al (1995) Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells. Biochemistry 34:8474–8480

    Article  CAS  PubMed  Google Scholar 

  • Bonner JA, Harari PM, Giralt J et al (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11:21–28

    Article  CAS  PubMed  Google Scholar 

  • Brizel DM, Albers ME, Fisher SR et al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798–1804

    Article  CAS  PubMed  Google Scholar 

  • Brunsvig PF, Andersen A, Aamdal S et al (2007) Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy. BMC Cancer 7:197

    Article  PubMed  CAS  Google Scholar 

  • Budach W, Gioioso D, Taghian A et al (1997) Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int J Radiat Oncol Biol Phys 39:743–750

    Article  CAS  PubMed  Google Scholar 

  • Budach W, Paulsen F, Welz S et al (2002) Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma. Br J Cancer 86:470–476

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Budach V, Stuschke M, Budach W et al (2005) Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23:1125–1135

    Article  CAS  PubMed  Google Scholar 

  • Byfield JE, Calabro-Jones P, Klisak I et al (1982) Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys 8:1923–1933

    Article  CAS  PubMed  Google Scholar 

  • Carde P, Laval F (1981) Effects of cis-dichlorodiammine platinum II and x rays on mammalian cell survival. Int J Radiat Oncol Biol Phys 7:929–933

    Article  CAS  PubMed  Google Scholar 

  • Chen HY, Ma XM, Ye M et al (2013) Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma. PLoS One 8:e73918

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Choo YC, Choy TK, Wong LC, et al (1986) Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma. Gynecol Oncol. 23(1):94–100.

    Google Scholar 

  • Chua DT, Sham JS, Leung LH et al (2005) Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol 77:290–294

    Article  PubMed  Google Scholar 

  • Cividalli A, Ceciarelli F, Livdi E et al (2002) Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys 52:1092–1098

    Article  CAS  PubMed  Google Scholar 

  • Combs SE, Bischof M, Welzel T et al (2008) Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (SFRT) in patients with recurrent gliomas. J Neurooncol 89:205–210

    Article  PubMed  Google Scholar 

  • Coughlin CT, Richmond RC, Page RL (1994) Platinum drug delivery and radiation for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 28:1029–1038

    Article  CAS  PubMed  Google Scholar 

  • de Geus-Oei LF, Vriens D, van Laarhoven HW et al (2009) Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. J Nucl Med 50(Suppl 1):43S–54S

    Article  PubMed  CAS  Google Scholar 

  • Dewit L (1987) Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13:403–426

    Article  CAS  PubMed  Google Scholar 

  • Dolling JA, Boreham DR et al (1998) Modulation of radiation-induced strand break repair by cisplatin in mammalian cells. Int J Radiat Biol 74:61–69

    Article  CAS  PubMed  Google Scholar 

  • Dornoff N, Weiss C, Rödel F et al (2015) Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck. Strahlenther Onkol 191:656–664

    Article  PubMed  Google Scholar 

  • Douglas JG, Rockhill JK, Olson JM et al (2006) Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas. J Pediatr Hematol Oncol 28:36–39

    CAS  PubMed  Google Scholar 

  • Driessens G, Harsan L, Browaeys P et al (2003) Assessment of in vivo chemotherapy-induced DNA damage in a p53-mutated rat tumor by micronuclei assay. Ann N Y Acad Sci 1010:775–779

    Article  CAS  PubMed  Google Scholar 

  • Duprez F, Madani I, Bonte K et al (2009) Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiother Oncol 93:563–569

    Article  PubMed  Google Scholar 

  • Durand RE, LePard NE (1994) Modulation of tumor hypoxia by conventional chemotherapeutic agents. Int J Radiat Oncol Biol Phys 29:481–486

    Article  CAS  PubMed  Google Scholar 

  • Durand RE, LePard NE (2000) Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice. Radiother Oncol 56:245–252

    Article  CAS  PubMed  Google Scholar 

  • Earnshaw WC, Heck MM (1985) Localization of topoisomerase II in mitotic chromosomes. J Cell Biol 100:1716–1725

    Article  CAS  PubMed  Google Scholar 

  • Ekshyyan O, Rong Y, Rong X et al (2009) Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma. Mol Cancer Ther 8:2255–2265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eliaz RE, Nir S, Marty C, Szoka FC Jr (2004) Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res 64:711–718

    Article  CAS  PubMed  Google Scholar 

  • El-Sayed S, Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838–847

    Article  CAS  PubMed  Google Scholar 

  • Epstein RJ (1990) Drug-induced DNA damage and tumor chemosensitivity. J Clin Oncol 8:2062–2084

    Article  CAS  PubMed  Google Scholar 

  • Espinosa M, Martinez M, Aguilar JL et al (2005) Oxaliplatin activity in head and neck cancer cell lines. Cancer Chemother Pharmacol 55:301–305

    Article  CAS  PubMed  Google Scholar 

  • Fink D, Zheng H, Nebel S et al (1996) The role of DNA mismatch repair in platinum drug resistance. Cancer Res 56:4881–4886

    CAS  PubMed  Google Scholar 

  • Fogh SE, Andrews DW, Glass J et al (2010) Hypofrationated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 28:3048–3053

    Article  PubMed  PubMed Central  Google Scholar 

  • Fokas E, Wacker U, Gross MW et al (2009) Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 185:235–240

    Article  PubMed  Google Scholar 

  • Folkvord S, Flatmark K, Seierstad T et al (2008) Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity? Radiother Oncol 86:428–434

    Article  CAS  PubMed  Google Scholar 

  • Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098

    Article  CAS  PubMed  Google Scholar 

  • Geard CR, Jones JM (1994) Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 29:565–569

    Article  CAS  PubMed  Google Scholar 

  • Geh JI, Bond SJ, Bentzen SM et al (2006) Systemic overview of preoperative (neoadjuvant) chemoradiotherapy in patients with oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 78:236–244

    Article  CAS  PubMed  Google Scholar 

  • Gerard J, Romestaing P, Bonnetain F et al (2005) Preoperative chemoradiotherapy (CT-RT) improves local control in T3-4 rectal cancers: results of the FFCD 9203 randomized trial (Abstract). Int J Radiat Oncol Biol Phys 63(Suppl 1):S2–S3

    Article  Google Scholar 

  • Giocanti N, Hennequin C, Balosso J et al (1993) DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide. Cancer Res 53:2105–2111

    CAS  PubMed  Google Scholar 

  • Grau C, Overgaard J (1988) Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay. Radiother Oncol 13:301–309

    Article  CAS  PubMed  Google Scholar 

  • Green JA, Kirwan JM, Tierney JF et al (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358:781–786

    Article  CAS  PubMed  Google Scholar 

  • Grenman R, Carey TE, McClatchey KD et al (1991) In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67:2741–2747

    Article  CAS  PubMed  Google Scholar 

  • Grosu AL, Weber WA, Franz M et al (2005) Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63:511–519

    Article  CAS  PubMed  Google Scholar 

  • Guan Y, Liu S, Wang HY et al (2016) Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma. Chin J Cancer 35:20

    Article  PubMed  PubMed Central  Google Scholar 

  • Haraf DJ, Weichselbaum RR, Vokes EE (1996) Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 7:913–918

    Article  CAS  PubMed  Google Scholar 

  • Heidelberger C, Chaudhuri NK, Danneberg P et al (1957) Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179:663–666

    Article  CAS  PubMed  Google Scholar 

  • Heidelberger C, Griesbach L, Montag BJ et al (1958) Studies on fluorinated pyrimidines. II. Effects on transplanted tumors. Cancer Res 18:305–317

    CAS  PubMed  Google Scholar 

  • Hennequin C, Giocanti N, Favaudon V (1996) Interaction of ionizing radiation with paclitaxel (taxol) and docetaxel (taxotere) in HeLa and SQ20B cells. Cancer Res 56:1842–1850

    CAS  PubMed  Google Scholar 

  • Heron DE, Rwigema JC, Gibson MK et al (2011) Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study. Am J Clin Oncol 34(2):165–172

    CAS  PubMed  Google Scholar 

  • Hoebers F, Heemsbergen W, Moor S et al (2011) Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity. Int J Radiat Oncol Biol Phys 81:e111–e118

    Article  PubMed  Google Scholar 

  • Hummel R, Hussey DJ, Haier J (2010) MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 46:298–311

    Article  CAS  PubMed  Google Scholar 

  • Iseli TA, Iseli CE, Rosenthal EL et al (2009) Postoperative reirradiation for mucosal head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 135:1158–1164

    Article  PubMed  Google Scholar 

  • Jentsch C, Beuthien-Baumann B, Troost EG et al (2015) Validation of functional imaging as a biomarker for radiation treatment response. Br J Radiol 88:20150014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jones B, Sanghera P (2007) Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma. Int J Radiat Oncol Biol Phys 68:441–448

    Article  PubMed  Google Scholar 

  • Joseph KJ, Al-Mandhari Z, Pervez N et al (2008) Reirradiation after radical radiation therapy: a survey of patterns of practice among Canadian radiation oncologists. Int J Radiat Oncol Biol Phys 72:1523–1529

    Article  PubMed  Google Scholar 

  • Joye I, Deroose CM, Vandecaveye V et al (2014) The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review. Radiother Oncol 113:158–165

    Article  PubMed  Google Scholar 

  • Kallman RF, Bedarida G, Rapacchietta D (1992) Experimental studies on schedule dependence in the treatment of cancer with combinations of chemotherapy and radiotherapy. Front Radiat Ther Oncol 26:31–44

    Article  CAS  PubMed  Google Scholar 

  • Kamoshima Y, Sawamura Y, Ikeda J et al (2008) Late recurrence and salvage therapy of CNS germinomas. J Neurooncol 90:205–211

    Article  PubMed  Google Scholar 

  • Kang H, Kiess A, Chung CH (2015) Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol 12:11–26

    Article  PubMed  Google Scholar 

  • Karam I, Huang SH, McNiven A et al (2015) Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience. Head Neck. doi:10.1002/hed.24166

    Google Scholar 

  • Kasibhatla M, Kirkpatrick JP, Brizel DM (2007) How much radiation is the chemotherapy worth in advanced head and neck cancer? Int J Radiat Oncol Biol Phys 68:1491–1495

    Article  PubMed  Google Scholar 

  • Kim JJ, Tannock IF (2005) Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5:516–525

    Article  CAS  PubMed  Google Scholar 

  • Kim JH, Kim SH, Kolozsvary A, Khil MS (1992) Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I. Int J Radiat Oncol Biol Phys 22:515–518

    Article  CAS  PubMed  Google Scholar 

  • Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15:986–994

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kjellstrom J, Kjellen E, Johnsson A (2005) In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line. Acta Oncol 44:687–693

    Article  PubMed  CAS  Google Scholar 

  • Kress MA, Sen N, Unger KR et al (2015) Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: long-term follow-up of a large series. Head Neck 37:1403–1409

    Article  PubMed  Google Scholar 

  • Landuyt W, Keizer J, Chin A et al (1987) Evaluation of mouse lip mucosa reactions after combinations of cis-diammine-1,1-cyclobutanedicarboxylate platinum (II) (CBDCA) and irradiation: single and fractionated treatments. Int J Radiat Oncol Biol Phys 13:1367–1370

    Article  CAS  PubMed  Google Scholar 

  • Lartigau EF, Tresch E, Thariat J et al (2013) Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol 109:281–285

    Article  CAS  PubMed  Google Scholar 

  • Lawrence TS, Davis MA, Maybaum J (1994) Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects. Int J Radiat Oncol Biol Phys 29:519–523

    Article  CAS  PubMed  Google Scholar 

  • Lawrence TS, Davis MA, Tang HY, Maybaum J (1996a) Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression. Int J Radiat Biol 70:273–280

    Article  CAS  PubMed  Google Scholar 

  • Lawrence TS, Davis MA, Loney TL (1996b) Fluoropyrimidine-mediated radiosensitization depends on cyclin E-dependent kinase activation. Cancer Res 56:3203–3206

    CAS  PubMed  Google Scholar 

  • Lawrence TS, Chang EY, Hahn TM (1996c) Radiosensitization of pancreatic cancer cells by 2’,2’-difluoro-2’-deoxycytidine. Int J Radiat Oncol Biol Phys 34:867–872

    Article  CAS  PubMed  Google Scholar 

  • Lee N, Chan K, Bekelman JE et al (2007) Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 68:731–740

    Article  PubMed  Google Scholar 

  • Linthorst M, Baaijens M, Wiggenraad R et al (2015) Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients. Radiother Oncol 117:217–222

    Article  PubMed  Google Scholar 

  • Magne N, Fischel JL, Formento P et al (2003) Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status. Oncology 64:280–287

    Article  CAS  PubMed  Google Scholar 

  • McGinn CJ, Miller EM, Lindstrom MJ et al (1994) The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization. Int J Radiat Oncol Biol Phys 30:851–859

    Article  CAS  PubMed  Google Scholar 

  • McGinn CJ, Shewach DS, Lawrence TS (1996) Radiosensitizing nucleosides. J Natl Cancer Inst 88:1193–1203

    Article  CAS  PubMed  Google Scholar 

  • Milas L, Hunter NR, Mason KA et al (1994) Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 54:3506–3510

    CAS  PubMed  Google Scholar 

  • Milas L, Hunter NR, Mason KA et al (1995) Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 55:3564–3568

    CAS  PubMed  Google Scholar 

  • Miller EM, Kinsella TJ (1992) Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization. Cancer Res 52:1687–1694

    CAS  PubMed  Google Scholar 

  • Miller SJ, Lavker RM, Sun TT (2005) Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. Biochim Biophys Acta 1756:25–52

    CAS  PubMed  Google Scholar 

  • Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 2006:583–592

    Article  CAS  Google Scholar 

  • Minniti G, Agolli L, Falco T et al (2015) Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas. J Neurooncol 122:559–566

    Article  CAS  PubMed  Google Scholar 

  • Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174

    Article  CAS  PubMed  Google Scholar 

  • Moertel CG, Childs DS Jr, Reitemeier RJ et al (1969) Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2:865–867

    Article  CAS  PubMed  Google Scholar 

  • Mohiuddin M, Marks G, Marks J (2002) Long-term results of reirradiation for patients with recurrent rectal cancer. Cancer 95:1144–1150

    Article  PubMed  Google Scholar 

  • Moitra K (2015) Overcoming multidrug resistance in cancer stem cells. Biomed Res Int 2015:635745. doi:10.1155/2015/635745

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Molls M, Vaupel P (1998) Blood perfusion and microenvironment of human tumors. Springer, Berlin/Heidelberg/New York

    Google Scholar 

  • Molls M, Vaupel P, Nieder C et al (2009) The impact of tumor biology on cancer treatment and multidisciplinary strategies. Springer, Berlin/Heidelberg/New York

    Book  Google Scholar 

  • Monk BJ, Alberts DS, Burger RA et al (1998) In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers. Gynecol Oncol 71:308–312

    Article  CAS  PubMed  Google Scholar 

  • Munro AJ (1995) An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83–91

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nagar YS, Singh S, Datta NR (2004) Chemo-reirradiation in persistent/recurrent head and neck cancers. Jpn J Clin Oncol 34:61–68

    Article  PubMed  Google Scholar 

  • Naida JD, Davis MA, Lawrence TS (1998) The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization. Int J Radiat Oncol Biol Phys 41:675–680

    Article  CAS  PubMed  Google Scholar 

  • Nieder C, Milas L, Ang KK (2003) Modification of radiation response: cytokines, growth factors, and other biological targets. Springer, Berlin/Heidelberg/New York

    Book  Google Scholar 

  • NIH consensus conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444–1450

    Article  Google Scholar 

  • Nordsmark M, Bentzen SM, Rudat V et al (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiotherapy. An international multicenter study. Radiother Oncol 77:18–24

    Article  PubMed  Google Scholar 

  • Nuyten DS, van de Vijver MJ (2008) Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity. Semin Radiat Oncol 18:105–114

    Article  PubMed  Google Scholar 

  • O’Connell MJ, Martenson JA, Wieand HS et al (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502–507

    Article  PubMed  Google Scholar 

  • Ohizumi Y, Tamai Y, Imamiya S et al (2002) Prognostic factors of reirradiation for recurrent head and neck cancer. Am J Clin Oncol 25:408–413

    Article  PubMed  Google Scholar 

  • Ormerod MG, Orr RM, Peacock JH (1994) The role of apoptosis in cell killing by cisplatin: a flow cytometric study. Br J Cancer 69:93–100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Overgaard J, Khan AR (1981) Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin. Cancer Treat Rep. 65(5–6):501–503

    Google Scholar 

  • Pekkola-Heino K, Kulmala J, Grenman R (1992) Carboplatin-radiation interaction in squamous cell carcinoma cell lines. Arch Otolaryngol Head Neck Surg 118:1312–1315

    Article  CAS  PubMed  Google Scholar 

  • Pendyala L, Creaven PJ (1993) In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Cancer Res 53:5970–5976

    CAS  PubMed  Google Scholar 

  • Pignon JP, Bourhis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949–955

    Article  CAS  PubMed  Google Scholar 

  • Pignon JP, le Maître A, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14

    Article  PubMed  Google Scholar 

  • Pilones KA, Vanpouille-Box C, Demaria S (2015) Combination of radiotherapy and immune checkpoint inhibitors. Semin Radiat Oncol 25:28–33

    Article  PubMed  Google Scholar 

  • Pinedo HM, Peters GF (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6:1653–1664

    Article  CAS  PubMed  Google Scholar 

  • Popovtzer A, Gluck I, Chepeha DB et al (2009) The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys 74:1342–1347

    Article  PubMed  PubMed Central  Google Scholar 

  • Primeau AJ, Rendon A, Hedley D et al (2005) The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 11:8782–8788

    Article  CAS  PubMed  Google Scholar 

  • Prince ME, Ailles LE (2008) Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 26:2871–2875

    Article  PubMed  Google Scholar 

  • Raaphorst GP, Leblanc M, Li LF (2005) A comparison of response to cisplatin, radiation and combined treatment for cells deficient in recombination repair pathways. Anticancer Res 25:53–58

    CAS  PubMed  Google Scholar 

  • Rau B, Sturm I, Lage H et al (2003) Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol 21:3391–3401

    Article  CAS  PubMed  Google Scholar 

  • Raymond E, Faivre S, Chaney S et al (2002) Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther 1:227–235

    CAS  PubMed  Google Scholar 

  • Richmond RC, Powers EL (1976) Radiation sensitization of bacterial spores by cis-dichlorodaimmineplatinum (II). Radiat Res 68:251

    Article  CAS  PubMed  Google Scholar 

  • Rockwell S (1982) Cytotoxicities of mitomycin C and X rays to aerobic and hypoxic cells in vitro. Int J Radiat Oncol Biol Phys 8:1035–1039

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg B, van Camp L, Krigas T (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205:698–699

    Article  CAS  PubMed  Google Scholar 

  • Rusthoven KE, Feigenberg SJ, Raben D et al (2010) Initial results of a phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 78(4):1020–5

    Article  CAS  PubMed  Google Scholar 

  • Salama JK, Vokes EE, Chmura SJ et al (2006) Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 64:382–391

    Article  PubMed  Google Scholar 

  • Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740

    Article  CAS  PubMed  Google Scholar 

  • Scalliet P, De Pooter C, Hellemans PW et al (1999) Interactions of carboplatin, cisplatin, and ionizing radiation on a human cell line of ovarian cancer (French). Cancer Radiother 3:30–38

    Article  CAS  PubMed  Google Scholar 

  • Schaake-Koning C, van den Bogaert W, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524–530

    Article  CAS  PubMed  Google Scholar 

  • Schaefer U, Micke O, Schueller P et al (2000) Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study. Radiology 216:371–376

    Article  CAS  PubMed  Google Scholar 

  • Schöder H, Ong SC (2008) Fundamentals of molecular imaging: rationale and applications with relevance for radiation oncology. Semin Nucl Med 38:119–128

    Article  PubMed  Google Scholar 

  • Schwachöfer JHM, Crooijmans RP, Hoogenhout J et al (1991) Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int J Radiat Oncol Biol Phys 20:1235–1241

    Article  PubMed  Google Scholar 

  • Schaake-Koning C, Maat B, van Houtte P, van den Bogaert W, Dalesio O, Kirkpatrick A, Bartelink H (1990) Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups. Int J Radiat Oncol Biol Phys.19(4):967–972

    Google Scholar 

  • Seiwert TY, Haraf DJ, Cohen EE et al (2008) Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based oncomitant chemoradiotherapy for poor-prognosis head and neck cancer. J Clin Oncol 26:1732–1741

    Article  CAS  PubMed  Google Scholar 

  • Simoens C, Korst AE, De Pooter CM et al (2003) In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects. Br J Cancer 89:2305–2311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spencer SA, Harris J, Wheeler RH et al (2008) Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 30:281–288

    Article  PubMed  Google Scholar 

  • Steel GG (1979) Terminology in the description of drug-radiation interactions. Int J Radiat Oncol Biol Phys 5:1145–1150

    Article  CAS  PubMed  Google Scholar 

  • Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy–chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5:85–91

    Article  CAS  PubMed  Google Scholar 

  • Strnad V, Lotter M, Kreppner S et al (2015) Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy. Strahlenther Onkol 191:495–500

    Article  PubMed  Google Scholar 

  • Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  CAS  PubMed  Google Scholar 

  • Sulman EP, Schwartz DL, Le TT et al (2009) IMRT reirradiation of head and neck cancer – disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 73:399–409

    Article  PubMed  Google Scholar 

  • Tannock IF (1989) Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 16:83–101

    Article  CAS  PubMed  Google Scholar 

  • Tannock IF (1992) Potential for therapeutic gain from combined-modality treatment. Front Radiat Ther Oncol 26:1–15

    Article  CAS  PubMed  Google Scholar 

  • Tannock IF (1998) Conventional cancer therapy: promise broken or promise delayed? Lancet 351(Suppl 2):SII9–SII16

    Article  PubMed  Google Scholar 

  • Tannock IF, Lee CM, Tunggal JK et al (2002) Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 8:878–884

    CAS  PubMed  Google Scholar 

  • Tanvetyanom T, Padhya T, McCaffrey J et al (2009) Prognostic factors for survival after salvage reirradiation of head and neck cancer. J Clin Oncol 27:1983–1991

    Article  Google Scholar 

  • Taylor DM, Tew KD, Jones JD (1976) Effects of cis-dichlorodiammine platinum (II) on DNA synthesis in kidney and other tissues of normal and tumoour-bearing rats. Eur J Cancer 12:249–254

    Article  CAS  PubMed  Google Scholar 

  • Teicher BA, Lazo JS, Sartorelli AC (1981) Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41:73–81

    CAS  PubMed  Google Scholar 

  • Thames HD, Suit HD (1986) Tumor radioresponsiveness versus fractionation sensitivity. Int J Radiat Oncol Biol Phys 12:687–691

    Article  CAS  PubMed  Google Scholar 

  • Trott KR (1990) Cell repopulation and overall treatment time. Int J Radiat Oncol Biol Phys 19:1071–1075

    Article  CAS  PubMed  Google Scholar 

  • Turchi JJ, Patrick SM, Henkels KM (1997) Mechanism of DNA-dependent protein kinase inhibition by cis-diamminedichloro-platinum(II)-damaged DNA. Biochemistry 36:7586–7593

    Article  CAS  PubMed  Google Scholar 

  • Unger KR, Lominska CE, Deeken JF et al (2010) Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 77:1411–1419

    Article  PubMed  Google Scholar 

  • Van Waes C, Chang AA, Lebowitz PF et al (2005) Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 63:1400–1412

    Article  PubMed  CAS  Google Scholar 

  • VanderSpek L, Fisher B, Bauman G et al (2008) 3D conformal radiotherapy and cisplatin for recurrent malignant glioma. Can J Neurol Sci 35:57–64

    Article  PubMed  Google Scholar 

  • Vargo JA, Ferris RL, Ohr J et al (2015) A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 91:480–488

    Article  PubMed  Google Scholar 

  • Volm M, Efferth T (2015) Prediction of cancer drug resistance and implications for personalized medicine. Front Oncol 5:282

    Article  PubMed  PubMed Central  Google Scholar 

  • Wahl AO, Rademaker A, Kiel KD et al (2008) Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int J Radiat Oncol Biol Phys 70:477–484

    Article  PubMed  Google Scholar 

  • Weber WA (2005) Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 46:983–995

    CAS  PubMed  Google Scholar 

  • Weichselbaum RR, Beckett MA, Schwartz JL et al (1988) Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys 15:575–579

    Article  CAS  PubMed  Google Scholar 

  • Woynarowski JM, Chapman WG, Napier C et al (1998) Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. Mol Pharmacol 54:770–777

    CAS  PubMed  Google Scholar 

  • Wu HI, Brown JA, Dorie MJ et al (2004) Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin C. Cancer Res 64:3940–3948

    Article  CAS  PubMed  Google Scholar 

  • Wurm RE, Kuczer DA, Schlenger L et al (2006) Hypofractionated stereotactic radiotherapy combined with topotecan in recurrent malignant glioma. Int J Radiat Oncol Biol Phys 66:S26–S32

    Article  Google Scholar 

  • Würschmidt F, Dahle J, Petersen C et al (2008) Reirradiation of recurrent breast cancer with and without concurrent chemotherapy. Radiat Oncol 3:28

    Article  PubMed  PubMed Central  Google Scholar 

  • Yamazaki H, Ogita M, Himei K et al (2015) Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife. Radiat Oncol 10:210

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yang LX, Douple EB, O’Hara JA, Wang HJ (1995) Production of DNA double-strand breaks by interactions between carboplatin and radiation: a potential mechanism for radiopotentiation. Radiat Res 143:309–315

    Article  CAS  PubMed  Google Scholar 

  • Yang YC, Chao KS, Lin CP et al (2009) Oxaliplatin regulates DNA repair responding to ionizing radiation and enhances radiosensitivity of human cervical cancer cells. Int J Gynecol Cancer 19:782–786

    Article  PubMed  Google Scholar 

  • Yang J, Parsons J, Nicolay NH et al (2010) Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy. Oncogene 29:463–468

    Article  CAS  PubMed  Google Scholar 

  • Yoshida GJ, Saya H (2015) Therapeutic strategies targeting cancer stem cells. Cancer Sci. doi:10.1111/cas.12817

    Google Scholar 

  • Yu YQ, Giocanti N, Averbeck D et al (2000) Radiation-induced arrest of cells in G2 phase elicits hypersensitivity to DNA double-strand break inducers and an altered pattern of DNA cleavage upon re-irradiation. Int J Radiat Biol 76:901–912

    Article  CAS  PubMed  Google Scholar 

  • Zak M, Drobnik J (1971) Effects of cis-dichlorodiammineplatinum (II) on the post irradiation lethality in mice after irradiation with X-rays. Strahlentherapie 142:112–115

    CAS  PubMed  Google Scholar 

  • Zamboni WC, Gervais AC, Egorin MJ et al (2002) Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin. Clin Cancer Res 8:2992–2999

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology and Palliative Medicine, Nordland Hospital, Prinsensgate 164, Bodo, 8092, Norway

    Carsten Nieder MD

  2. Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI, 48109-5010, USA

    Avraham Eisbruch MD

Authors
  1. Carsten Nieder MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Avraham Eisbruch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carsten Nieder MD .

Editor information

Editors and Affiliations

  1. Department of Oncology, University of Tromso and Nordland Hospital, Bodo, Norway

    Carsten Nieder

  2. University Medical Center Groningen, Groningen, The Netherlands

    Johannes Langendijk

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Nieder, C., Eisbruch, A. (2016). Therapeutic Ratio of Reirradiation with Cytotoxic Drugs and Other Response-Modifying Agents. In: Nieder, C., Langendijk, J. (eds) Re-Irradiation: New Frontiers. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2016_62

Download citation

  • DOI: https://doi.org/10.1007/174_2016_62

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-41823-0

  • Online ISBN: 978-3-319-41825-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation